Barclays PLC Biodesix Inc Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
A detailed history of Barclays PLC transactions in Biodesix Inc stock. As of the latest transaction made, Barclays PLC holds 23,036 shares of BDSX stock, worth $31,789. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,036
Previous 23,036
-0.0%
Holding current value
$31,789
Previous $41,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BDSX
# of Institutions
58Shares Held
62.3MCall Options Held
2.6KPut Options Held
10.1K-
Telemark Asset Management, LLC Boston, MA8.28MShares$11.4 Million1.58% of portfolio
-
Bryn Mawr Trust CO Bryn Mawr, PA6.1MShares$8.41 Million0.2% of portfolio
-
Aigh Capital Management LLC Baltimore, MD5.68MShares$7.84 Million4.09% of portfolio
-
Birchview Capital, LP Burlington, VT5.54MShares$7.65 Million9.1% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.64MShares$6.4 Million0.04% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $55.2M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...